Anthra definition

Anthra means Anthra Pharmaceuticals, Inc. and its Affiliates.
View Source
Anthra or the "Company") and one Class A redeemable Common Stock purchase warrant (the "Warrant"), each Warrant entitling the holder thereof to purchase one share of Common Stock at an exercise price of $6.00 per share, subject to adjustment in certain events, exercisable at any time during the period beginning on __________ __, 1999 or on such earlier date as determined by the Underwriter (the "Separation Date") and ending on __________ __, 2003 (unless earlier redeemed). The terms of this Unit and the Warrants are governed by a Unit and Warrant Agreement, dated as of September __, 1998 (the "Unit and Warrant Agreement"), between the Company and American Stock Transfer & Trust Company, as Unit Agent, Warrant Agent and Transfer Agent, and are subject to the terms and provisions contained therein. The Registered Holder of this Unit Certificate consents to all of the terms and provisions contained in the Unit and Warrant Agreement by acceptance hereof. Copies of the Unit and Warrant Agreement are on file at the office of the Unit Agent at 40 W▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇▇▇, ▇▇d are available to any holder on written request without cost. This certificate is not valid unless countersigned and registered by the Unit Agent. The Warrants and shares of Common Stock of the Company represented by this Unit Certificate shall not be separately transferable until the Separation Date. On and after the Separation Date, the Registered Holder of this Unit Certificate may surrender it to the Unit Agent at its Corporate Office specified in the Unit and Warrant Agreement in exchange for the Warrants and shares of Common Stock represented hereby. The Units represented by this Unit Certificate shall not be transferable on and subsequent to the Separation Date. On and subsequent to the Separation Date, the Warrants and the shares of Common Stock represented by this Unit Certificate may only be separately transferred.
View Source
Anthra has advised Leiras that Anthra will obtain from its patent counsel an opinion as to whether Marketing or sale of the Product in the Territory may infringe Boehringer Mannheim ("BM"), U.S. patent no. 4,859,472. Following receipt of the opinion of Anthra patent counsel, Anthra will furnish Leiras with a copy thereof and Leiras, Leiras' patent counsel, Anthra and Anthra's patent counsel shall consult with each other, and if the opinion of Anthra patent counsel or Leiras patent counsel, or both, is that there is or may be infringement, then, either Leiras or Anthra may, by written notice to the other, advise the other that it is necessary or desirable to obtain a license with respect to the Product under such patent from BM for the Territory. Thereafter either Leiras or Anthra may commence negotiations with BM with the objective of obtaining license for both Leiras and Anthra and their respective Affiliates, and Leiras and Anthra shall cooperate in such negotiations and each allow the other, to the extent practicable, to participate in its negotiation. Any license negotiated shall provide for a royalty not to exceed five percent (5%) of Net Sales of Products with no up front cash payment, unless otherwise mutually agreed by the parties. As between Leiras and Anthra, Leiras shall be liable for 32.5% of the royalties and Anthra shall be liable for 67.5% of the royalties, and the royalties shall be counted as royalties under Section 13.6 clause (z) of this Development Agreement and corresponding Section 12.6 clause (z) of the Manufacturing Agreement for purposes of 59 determining when the aggregate of 9,230,769 US Dollars under Sections 13.6 and 12.6 thereof, respectively, has been reached, and thereafter, Anthra, in addition to its other obligations thereunder, shall be liable for one hundred percent (100%) of the royalties due to BM under the license.
View Source

Examples of Anthra in a sentence

  • All notices, requests, reports, statements and other communications to either party (each a "Notice") shall be in writing, in the English language, shall refer specifically to this Agreement and shall be hand delivered or sent by express courier service, carriage costs prepaid, or by facsimile to the respective addresses specified below (or to such other address as may be specified by Notice to the other party): If to Anthra: Anthra Pharmaceuticals, Inc.

  • Anthra shall maintain all records necessary to comply with all applicable laws, rules and regulations in the Territory relating to the manufacturing of the Product.

  • The expenses of the Testing Laboratory shall be borne by Genchem Pharma if the testing confirms the non-conformity, and otherwise by Anthra.

  • Anthra shall have the sole right to file for, obtain, maintain, register and extend patent protection for the Licensed Know-how, and to control the prosecution of applications therefor.

  • Medeva shall order a shipment of the Product by issuing a purchase order to Anthra specifying the quantity and desired delivery date thereof, not less than *** prior to the delivery date; provided, however, that the aggregate quantity of Product ordered by Medeva for delivery in any month shall not exceed *** CONFIDENTIAL TREATMENT REQUESTED.

  • Anthra shall maintain, and shall cause its Contract Manufacturers and other agents to maintain, all *** CONFIDENTIAL TREATMENT REQUESTED.

  • Upon the termination or expiration of this Agreement, Anthra shall have the option (the "Purchase Option"), exercisable upon written notice to Medeva, to purchase the Medeva Interest for an amount equal to the fair market value thereof at the time of exercise.

  • In the event that any process event shall occur in the manufacturing of any batch of Product, which event is likely materially to affect the safety, efficacy or regulatory status of the Product, then Anthra shall notify Medeva as soon as reasonably possible.

  • Promptly upon the completion (and prior to the filing) of each such NDA, Anthra shall provide Medeva with a copy of the Chemistry, Manufacturing, and Controls (CMC) section thereof, and agrees to delay the filing of such NDA with the FDA for a period of sixty (60) days after the date such copy was provided to Medeva, unless the EMC shall unanimously approve the filing of such NDA prior to the end of such period.

  • Within sixty (60) days after Anthra becomes, or is made, aware of any of the foregoing, it shall decide whether or not to initiate an infringement or other appropriate action or suit and shall advise Medeva of its decision in writing.